Medical Equipment Supplier

Azur Medical

]Azur Medical started operations in 2013.
]Our company provides Laboratory Diagnostics and Medical Equipment, and Specialised Medical Consumables for the local market in Mauritius and across the Indian Ocean region. We work in close partnership with leading global brands, acting as the official distributor of well-recognised products.
]Our portfolio covers Point-of-Care (POC) testing, Cardiology, Urology, Endoscopy, Ostomy and Imaging solutions, supporting a broad spectrum of clinical and diagnostic requirements. In recognition of our operational performance, we have also received supplier awards for outstanding performance and are on the approved vendor list of the Ministry of Health and Wellness of Mauritius.

]We serve a diverse and well-established customer base, including Ministries of Health in Mauritius, Seychelles and Comoros, as well as private hospitals, clinics and diagnostic laboratories. Our company also works closely with non-governmental organisations and international development bodies, including the World Health Organisation and the Pasteur Institute of Madagascar.
]Deliveries in the region are organised either directly from suppliers or via Azur Medical’s logistics hub, depending on product requirements and lead times. Moreover, we maintain dedicated technical sales expertise in Madagascar, while Seychelles and Comoros are serviced on a needs-based model from Mauritius, ensuring flexibility and cost-effective regional coverage.

]May 2007 - Incorporation of Azur Medical Ltd
]2013 - Commencement of commercial operations
]December 2022 - Kibo Capital Partners, through its special purpose vehicle Kibo Healthcare 1 Ltd (KH1), initiates the acquisition of Azur Medical Ltd
]April 2023 - Relocation to new offices at Vivéa Business Park
]January 2024 - Establishment of the Medical Division under the leadership of Mrs Véronique Gaudet

]August 2024 - Appointment of a new Board of Directors under the chairmanship of Mr Vivian Masson
]January 2025 - KH1 completes the acquisition of a 75% shareholding in Azur Medical Ltd
]March 2025 - Establishment of the High-End Life Sciences Division under the leadership of Mr Niteeraj Seebrun